ENTITY
Mezzion Pharma

Mezzion Pharma (140410 KS)

15
Analysis
Health CareSouth Korea
Mezzion Pharma Co Ltd develops pharmaceutical products and out-licenses them to foreign countries including Canada, Mexico, Russia, and the United States. The Company's main products are for benign prostatic hyperplasia and erectile dysfunction.
more
16 Oct 2019 06:41

Korea - The Shorts Must Be Crazy (On Some Names)!

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 11 October.Current...

Logo
406 Views
Share
26 Aug 2018 23:31

EM Strategy: Remain Overweight India

In this report we provide a synopsis of EM markets. We also scour the EM universe for attractive and actionable opportunities, highlighting...

Logo
431 Views
Share
01 Jun 2017 14:39

Summary of KOSPI200 & KOSDAQ150 Upcoming Reshuffle

As I said in my earlier comment, Samsung Biologics Co., Ltd (207940 KS) seems to be benefiting a lot from its inclusion in KOSPI200 index. Perhaps...

Logo
2.2k Views
Share
07 Jul 2016 00:13

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...

Logo
3.5k Views
Share
x